𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Application of allele-specific RNAi in hepatitis B virus lamivudine resistance

✍ Scribed by X. Teng; J.-Y. Liu; D. Li; Y. Fang; X.-Y. Wang; Y.-X. Ma; S.-J. Chen; Y.-X. Zhao; W.-Z. Xu; H.-X. Gu

Book ID
108886625
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
451 KB
Volume
18
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Susceptibility of hepatitis B virus to l
Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir
✍ H.L. Zaaijer; R.B. Takkenberg; C.J. Weegink; S.P.H. Rebers; S. Menting; H.W. Ree 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract Serial monotherapy and add‐on regimes for treatment of chronic hepatitis B virus (HBV) infection may induce the accumulation of viral resistance mutations in patients, reducing the options for ongoing viral suppression. The induction of antiviral resistance by serial application of poly

Long-term incidence of hepatitis B virus
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients
✍ Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Di Martino; Eric Caumes; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin

Dynamics of lamivudine-resistant hepatit
Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy
✍ Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Adefovir dipivoxil has been used alone or together with lamivudine to suppress lamivudine‐resistant hepatitis B virus (HBV). However, the dynamics of HBV populations under different selection pressures and their impact on treatment outcome are poorly understood. Pyrosequencing® was appl